aibio
Debt Financing ·
OPKO issues $125,000,000 in additional senior secured notes
The notes mature in July 2044 and are secured by royalty payments that EirGen Pharma Limited receives on mazdutide. HCR Injection SPV, LLC serves as agent.
OPK OPKO HEALTH, INC.
OPKO HEALTH, INC. (OPK) news
Latest OPKO HEALTH, INC. news
- Financings
Cocrystal sells $5 million of stock to OPKO Health
OPKO Health, a longtime shareholder, buys 5,474,053 shares at $0.9134 each in a private placement with no warrants attached.
- Financings
OPKO Health buys 3,685,226 Entera Bio shares at $2.17 in obesity collaboration
The two companies will hold 60% and 40% ownership interests in an oral GLP-1/glucagon program. Entera says the proceeds will fund its 40% share through Phase 1.
OPKO HEALTH, INC. annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $606.9 million | $713.1 million |
| Research and development | $124.0 million | $105.2 million |
| Net income (loss) | -$225.7 million | -$53.2 million |
| Cash from operations | -$178.5 million | -$183.5 million |
| Cash and equivalents | $364.4 million | $426.6 million |
Questions about OPKO HEALTH, INC.
What is the ticker symbol of OPKO HEALTH, INC.?
OPKO HEALTH, INC. trades under the ticker OPK on NASDAQ.
Where is OPKO HEALTH, INC. listed?
OPKO HEALTH, INC. is listed on NASDAQ.
Which country or territory is OPKO HEALTH, INC. listed under?
Our directory records OPKO HEALTH, INC. under United States.
Does aibio.space cover OPKO HEALTH, INC.?
aibio.space lists OPKO HEALTH, INC. among 2,820 public biotech companies and publishes its news here as stories appear.
What was OPKO HEALTH, INC.'s revenue last year?
$606.9 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is OPKO HEALTH, INC. profitable?
OPKO HEALTH, INC. reported a net loss of $225.7 million for the fiscal year ended Dec 31, 2025, and used $178.5 million of cash in operations, per its annual report to the SEC.
How much does OPKO HEALTH, INC. spend on research and development?
$124.0 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does OPKO HEALTH, INC. have?
$300.8 million in cash at Jun 30, 2026, per its 10-Q/A.
What is the latest OPKO HEALTH, INC. (OPK) stock news?
Our latest story on OPKO HEALTH, INC., dated Aug 13, 2026: "OPKO issues $125,000,000 in additional senior secured notes". The notes mature in July 2044 and are secured by royalty payments that EirGen Pharma Limited receives on mazdutide. HCR Injection SPV, LLC serves as agent. Source.
What is OPKO HEALTH, INC.'s latest stock offering or financing news?
Our latest financing story, dated Mar 17, 2025: "OPKO Health buys 3,685,226 Entera Bio shares at $2.17 in obesity collaboration". The two companies will hold 60% and 40% ownership interests in an oral GLP-1/glucagon program. Entera says the proceeds will fund its 40% share through Phase 1. Source.
Does OPKO HEALTH, INC. have debt, a term loan or convertible notes?
Our latest debt story, dated Aug 13, 2026: "OPKO issues $125,000,000 in additional senior secured notes". The notes mature in July 2044 and are secured by royalty payments that EirGen Pharma Limited receives on mazdutide. HCR Injection SPV, LLC serves as agent. Source.
How long will OPKO HEALTH, INC.'s cash last?
From our story of Mar 17, 2025: Entera's release lists its ability to continue as a going concern absent access to sources of liquidity among the factors that could cause actual results to differ from its forward-looking statements. Source.
Which other companies' news mentions OPKO HEALTH, INC.?
OPKO HEALTH, INC. is named in 1 of our story about other companies, most recently: "Cocrystal sells $5 million of stock to OPKO Health" (Aug 3, 2026). Source.
How can I follow OPKO HEALTH, INC. (OPK) news?
Press Follow on this page to add OPKO HEALTH, INC. to your Following list, or subscribe to the aibio.space newsletter. We have published 3 stories naming OPKO HEALTH, INC. so far, in Debt Financing, Financings.
Investor discussion: OPKO HEALTH, INC.
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
Listing details
- Company
- OPKO HEALTH, INC.
- Ticker
- OPK
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction